(Q35079620)

English

Review of the long-term effectiveness of cognitive behavioral therapy compared to medications in panic disorder

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

Review of the long-term effectiveness of cognitive behavioral therapy compared to medications in panic disorder (English)

1 reference

Europe PubMed Central

6 August 2017

cognitive behavioral therapy

1 reference

based on heuristic

inferred from title

author name string

Deepa N Nadiga

1

1 reference

Europe PubMed Central

6 August 2017

Paula L Hensley

2

1 reference

Europe PubMed Central

6 August 2017

E H Uhlenhuth

3

1 reference

Europe PubMed Central

6 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2003

1 reference

Europe PubMed Central

6 August 2017

Depression and Anxiety

1 reference

Europe PubMed Central

6 August 2017

17

1 reference

Europe PubMed Central

6 August 2017

2

1 reference

Europe PubMed Central

6 August 2017

58-64

1 reference

Europe PubMed Central

6 August 2017

ECT, research, and professional ambivalence

1 reference

https://api.crossref.org/works/10.1002%2FDA.10084

7 January 2021

based on heuristic

inferred from DOI database lookup

Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FDA.10084

7 January 2021

based on heuristic

inferred from DOI database lookup

Panic attacks in the community. Social morbidity and health care utilization

1 reference

https://api.crossref.org/works/10.1002%2FDA.10084

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia.

1 reference

https://api.crossref.org/works/10.1002%2FDA.10084

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.

1 reference

https://api.crossref.org/works/10.1002%2FDA.10084

7 January 2021

based on heuristic

inferred from DOI database lookup

Panic: course, complications and treatment of panic disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.10084

7 January 2021

based on heuristic

inferred from DOI database lookup

Panic disorder: long-term pharmacotherapy and discontinuation

1 reference

https://api.crossref.org/works/10.1002%2FDA.10084

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper

1 reference

https://api.crossref.org/works/10.1002%2FDA.10084

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants

1 reference

https://api.crossref.org/works/10.1002%2FDA.10084

7 January 2021

based on heuristic

inferred from DOI database lookup

The cross-national epidemiology of panic disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.10084

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DA.10084

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35079620&oldid=1757909696"